1995 - Fellow of the American Association for the Advancement of Science (AAAS)
1980 - Fellow of John Simon Guggenheim Memorial Foundation
Member of the Association of American Physicians
His primary areas of investigation include Vasculitis, Internal medicine, Rheumatology, Pathology and Dermatology. His Vasculitis research is multidisciplinary, relying on both Radiology and Blood pressure. William P. Arend is interested in Polyarteritis nodosa, which is a field of Internal medicine.
His research in Rheumatology tackles topics such as Arteritis which are related to areas like Purpura. He specializes in Pathology, namely Biopsy. The concepts of his Dermatology study are interwoven with issues in Granulomatosis with polyangiitis, Birmingham Vasculitis Activity Score and Surgery.
Molecular biology, Immunology, Internal medicine, Interleukin and Arthritis are his primary areas of study. The Molecular biology study combines topics in areas such as Cell culture, Biochemistry, Messenger RNA, Monocyte and Western blot. His studies deal with areas such as Gastroenterology and Endocrinology as well as Internal medicine.
His Interleukin study deals with Interleukin 1 receptor antagonist intersecting with Interleukin 1 receptor, type I. His Arthritis research incorporates themes from Alternative complement pathway, Antibody, Complement system and Immune complex. His Vasculitis study integrates concerns from other disciplines, such as Dermatology and Surgery, Arteritis.
His scientific interests lie mostly in Vasculitis, Internal medicine, Immunology, Alternative complement pathway and Rheumatology. His Vasculitis study necessitates a more in-depth grasp of Pathology. His research in Internal medicine is mostly concerned with Polyarteritis nodosa.
His Immunology research focuses on subjects like Receptor, which are linked to Tumor necrosis factor alpha and Complement membrane attack complex. William P. Arend interconnects Molecular biology and In vitro, Biochemistry in the investigation of issues within Alternative complement pathway. His study explores the link between Rheumatology and topics such as Arteritis that cross with problems in Purpura.
The scientist’s investigation covers issues in Vasculitis, Internal medicine, Pathology, Rheumatology and Dermatology. His studies in Vasculitis integrate themes in fields like Radiology and Blood pressure. William P. Arend is interested in Biopsy, which is a branch of Internal medicine.
In his study, Palpable purpura, Purpura, Henoch-Schonlein purpura and IgA vasculitis is strongly linked to Arteritis, which falls under the umbrella field of Rheumatology. His Dermatology research incorporates elements of Granulomatosis with polyangiitis, Birmingham Vasculitis Activity Score, Surgery, MEDLINE and Systemic disease. His Birmingham Vasculitis Activity Score research incorporates elements of Mononeuritis Multiplex, Eosinophilia, Asthma and Systemic vasculitis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Gene G. Hunder;Gene G. Hunder;Daniel A. Bloch;Daniel A. Bloch;Beat A. Michel;Mary Betty Stevens;Mary Betty Stevens.
Arthritis & Rheumatism (2010)
The American College of Rheumatology 1990 criteria for the classification of churg‐strauss syndrome (allergic granulomatosis and angiitis)
Alfonse T. Masi;Alfonse T. Masi;Gene G. Hunder;Gene G. Hunder;J. T. Lie;J. T. Lie;Beat A. Michel.
Arthritis & Rheumatism (2010)
The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis.
William P. Arend;Beat A. Michel;Daniel A. Bloch;Gene G. Hunder.
Arthritis & Rheumatism (2010)
The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.
Randi Y. Leavitt;Randi Y. Leavitt;Anthony S. Fauci;Anthony S. Fauci;Daniel A. Bloch;Daniel A. Bloch;Beat A. Michel.
Arthritis & Rheumatism (2010)
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Charles H. Hannum;Carol J. Wilcox;William P. Arend;Fenneke G. Joslin.
Nature (1990)
Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist
Stephen P. Eisenberg;Ron J. Evans;William P. Arend;Evie Verderber.
Nature (1990)
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
William P. Arend;Mark Malyak;Carla J. Guthridge;Cem Gabay.
Annual Review of Immunology (1998)
Inhibition of the production and effects of interleukins‐1 and tumor necrosis factor α in rheumatoid arthritis
William P. Arend;Jean‐Michel Dayer.
Arthritis & Rheumatism (1995)
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.
William P. Arend;Jean-Michel Dayer.
Arthritis & Rheumatism (1990)
The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosa
Robert W. Lightfoot;Robert W. Lightfoot;Beat A. Michel;Daniel A. Bloch;Daniel A. Bloch;Gene G. Hunder;Gene G. Hunder.
Arthritis & Rheumatism (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Colorado Denver
University of California, San Diego
Mayo Clinic
University of Illinois at Chicago
Cleveland Clinic
National Institute of Allergy and Infectious Diseases
Stanford University
Harvard University
Brigham and Women's Hospital
Stanford University
Rutgers, The State University of New Jersey
Southeast University
University of Barcelona
University of Sassari
University of Queensland
INRAE : Institut national de recherche pour l'agriculture, l'alimentation et l'environnement
Collège de France
Johns Hopkins University
University of Liège
University of Newcastle Australia
University of Glasgow
Mayo Clinic
MedStar Washington Hospital Center
University of Washington
California Institute of Technology
University of Barcelona